Teva rejected opportunity to acquire Perrigo
Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) had an opportunity to acquire US pharmaceuticals company Perrigo Company (NYSE:PRGO; TASE:PRGO) a few months ago, and said it was not interested, More...
Perrigo rejects Mylan’s $29 billion takeover bid
The board of directors of Perrigo Company (NYSE:PRGO; TASE:PRGO) has unanimously rejected the offer by Mylan NV to buy all its shares for $29 billion. Two weeks after receiving the offer, the pharmaceutical More...
Perrigo good acquisition candidate for Teva – report
Bloomberg reports that increased competition with cheaper generics may push Teva to make a major acquisition soon. Perrigo Company (NYSE:PRGO; TASE:PRGO) may be a suitable acquisition for Teva Pharmaceutical More...
Perrigo sale could be disaster for Tel Aviv Stock Exchange
– The company is responsible for 10% of the trading turnover on the Tel Aviv 25 Index. /By Gali Weinreb and Tali Tsipori/ “Globes” made waves yesterday when it reported that Perrigo More...
Perrigo up for sale
– The pharmaceutical firm is seeking a merger at a good premium on its $20 billion market cap. – Sources inform “Globes” that pharmaceutical company Perrigo Company (NYSE:PRGO; TASE:PRGO) More...
Perrigo Shareholders Approve $8.6 Billion Acquisition Of Elan
– President and CEO Joseph C. Papa – Perrigo Company (NYSE:PRGO; TASE:PRGO) shareholders yesterday approved the acquisition of Ireland’s Elan Corporation plc (NYSE; LSE; Dublin: More...
Phillip Frost’s Opko to list on TASE Wednesday
– Opko Health will have the tenth highest market cap on the Tel Aviv 25 Index. – Phillip Frost / Getty – / By Gali Weinreb and Ron Steinblatt / Next week, Mellanox Technologies Ltd. (Nasdaq:MLNX; More...